Read five tips to learn more about how easy it can be to start the year off right.
Over a year of advocacy efforts have paid off as the bill now moves to the President for signature.
Lupus is the feature of a new publication by the largest non-profit alliance committed to making medical research a national priority.
This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.
We're honored to announce the winners of this year's Evelyn V. Hess Award and Mary Betty Stevens Young Investigator Prize.
30 researchers funded by the LFA are presenting this week at the annual scientific meeting of the American College of Rheumatology. #ACR16 is among the world’s largest gatherings where results of medical research studies in the area of rheumatology are presented for critical peer evaluation.
Most people enjoy an occasional happy hour with co-workers and friends. But what if you have lupus? We asked two members of our Medical-Scientific Advisory Council for their help in developing some guidelines.
Aurinia Pharmaceuticals has announced its plans for a single Phase III clinical trial for voclosporin in the treatment of lupus nephritis (LN).